🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and efficacy of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2004-08
Trial ID
NCT00759551
Treatments Being Tested
SARS-CoV-2 is a member of a class of viruses: angiotensin converting enzyme...
Status
Terminated
Location
University of Calgary - Foothills
Start Date
2020-10-09
Trial ID
NCT04606563
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
The purpose of this study is to compare the antihypertensive effect of azil...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01033071
The purpose of this study is to determine the efficacy and safety of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00846365
The purpose of this study is to determine the safety and efficacy of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00696241
To investigate the efficacy and safety of azilsartan compared to olmesartan...
Status
Unknown
Location
Beijing ANZHEN Hospital
Start Date
2015-01
Trial ID
NCT02407210
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00362115
The purpose of this study is to evaluate long term safety and tolerability ...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01309828
Treatments Being Tested
The goal of this retrospective cohort study is to determine if Angiotensin-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07262710